Comparative Pharmacology
Head-to-head clinical analysis: LOMOTIL versus MOTOFEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LOMOTIL versus MOTOFEN.
LOMOTIL vs MOTOFEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Diphenoxylate is a meperidine congener that acts as an opioid receptor agonist, inhibiting gastrointestinal motility and prolonging transit time; atropine is added to discourage abuse at high doses.
Combination of diphenoxylate (opioid agonist) and atropine (anticholinergic). Diphenoxylate acts on μ-opioid receptors in the gut to slow peristalsis and reduce fluid secretion; atropine is added to discourage abuse by causing unpleasant anticholinergic effects at high doses.
Adults: 2 tablets (2.5 mg diphenoxylate/0.025 mg atropine) orally four times daily until control of diarrhea is achieved; maintenance dose is 2 tablets once or twice daily. Maximum dose: 8 tablets (20 mg diphenoxylate) per day.
1 to 2 tablets orally every 6 hours as needed, not to exceed 8 tablets per day.
None Documented
None Documented
Diphenoxylate: 2.5-3.5 hours; Difenoxin (active metabolite): 12-24 hours. Clinically, antidiarrheal effect is prolonged due to metabolite accumulation.
Terminal elimination half-life: 20-24 hours; clinical context: once-daily dosing recommended
Primarily renal (50-70% as metabolites, <5% unchanged) and fecal (30-50% via biliary excretion).
Renal: ~60%; Fecal/Biliary: ~40%
Category C
Category C
Antidiarrheal
Antidiarrheal